See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2020_MERRIMACK_PHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001274792')"} |
Graph
Absolute values for 0001274792, MERRIMACK PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 18,692,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,390,000 |
| 4 | LiabilitiesCurrent | 2,770,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,169,000 |
| 9 | ResearchAndDevelopmentExpense | 11,100,000 |
| 10 | remainder_Expenses | -6,383,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,554,000 |
| 13 | remainder_ComprehensiveNetIncome | 9,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 20,082,000 |
| 1 | Liabilities | 2,770,000 |
| 2 | Expenses | 20,886,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 17,312,000 |
| 5 | NetIncome | -17,332,000 |
| 6 | ComprehensiveNetIncome | -17,327,500 |
| 7 | BaseVar | 23,650,500 |
| 8 | EconomicCapitalRatio | 1.09 |
Edgar->Model Mapping
Feature Distribution
Change over Time
